Proteome Sciences plc (LON:PRM – Get Free Report) shares reached a new 52-week low on Wednesday . The company traded as low as GBX 2.30 ($0.03) and last traded at GBX 2.40 ($0.03), with a volume of 1232701 shares trading hands. The stock had previously closed at GBX 2.76 ($0.03).
Proteome Sciences Trading Down 13.0 %
The business’s fifty day moving average is GBX 2.80 and its 200 day moving average is GBX 3.29. The company has a market cap of £7.08 million, a P/E ratio of -286.40 and a beta of 0.07.
About Proteome Sciences
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.
Featured Stories
- Five stocks we like better than Proteome Sciences
- What Investors Need to Know About Upcoming IPOs
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- Insider Trades May Not Tell You What You Think
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- What is an Earnings Surprise?
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Proteome Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proteome Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
